Moxetumomab
Product Specifications
CAS Number
1622075-65-3
Target
Immunology/Inflammation related|||ADC Antibody
Related Pathways
Antibody-drug Conjugate/ADC Related|||Immunology/Inflammation
Purity
0.978
Bioactivity
Moxetumomab is a monoclonal antibody targeting CD22, which can be used to synthesise the antibody-drug conjugate (ADC) Moxetumomab pasudotox for the study of hairy cell leukaemia (HCL) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15106906 1 Vial
Lentiviral human UBE2I shRNA (UAS) - Lentiviral human UBE2I shRNA (UAS, GFP) plasmid
Ask
View Details MBS6167541-01 0.1 mL
ARX (aristaless Related Homeobox, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS) (APC)
Ask
View Details MBS6167541-02 5x 0.1 mL
ARX (aristaless Related Homeobox, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS) (APC)
Ask
View Details MBS6202937-01 0.1 mL
RFX5 (DNA-binding Protein RFX5, Regulatory Factor X 5) (MaxLight 490)
Ask
View Details